Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cost‐effectiveness analysis of palivizumab as respiratory syncytial virus prophylaxis in preterm infants in Sweden
PaperCitations, authors & open-access status
Cost‐effectiveness analysis of palivizumab as respiratory syncytial virus prophylaxis in preterm infants in Sweden is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 22 citations, 2011 year and bronze oa status.
22
Citations
2011
Year
bronze
OA Status